| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
529 |
378 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
393 |
324 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
633 |
452 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
281 |
236 |
$12K |
| 87428 |
|
152 |
126 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
130 |
115 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
29 |
$840.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$406.80 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
18 |
$374.72 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30 |
29 |
$210.00 |